A near-infrared fluorescent probe for amyloid-β aggregates
Source abstract
Abstract
Abstract The deposition of amyloid-β (Aβ) aggregates in the brain is a hallmark of the Alzheimer's disease (AD)-affected brain. Various aggregated Aβ species, including oligomers and fibrils, are generated upon the aggregation process, and these Aβ aggregates have distinct biological properties. To non-invasively monitor the aggregation pathways of Aβ and identify the existence of certain Aβ species in biological environments, an effective strategy to detect Aβ species is necessary. Herein, we report a turn-on near-infrared (near-IR) fluorescent probe, 1, for Aβ aggregates, which consists of a donor-π-acceptor system with an Aβ-interacting moiety. Our probe, 1, shows a noticeable increase in near-IR fluorescence at ca. 710 nm in the presence of Aβ aggregates in aqueous media. In addition, the fluorescent response of 1 was altered depending on the degree of Aβ aggregation. Moreover, 1 indicates turn-on fluorescence with Aβ aggregates in living cells and is nontoxic under the condition used for live-cell imaging.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Cholinesterase and Neurodegenerative Diseases · Molecular Sensors and Ion Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Alzheimer's disease and the amyloid-β peptide10.3233/JAD-2010-1221 ↗
2. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization10.1021/cr3000994 ↗
3. Bioinorganic chemistry of Alzheimer's disease10.1021/cr300009x ↗
4. Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease10.1038/nchem.247 ↗
5. Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils10.1038/nsmb.1799 ↗
6. Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease10.1039/C5CC05264E ↗
7. Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors10.1039/C6CS00731G ↗
8. Amyloid oligomers: formation and toxicity of Aβ oligomers10.1111/j.1742-4658.2010.07568.x ↗
9. Untangling amyloid-β, tau, and metals in Alzheimer's disease10.1021/cb400080f ↗
10. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches10.1038/nn1335 ↗
11. Molecular mechanism of thioflavin-T binding to amyloid fibrils10.1016/j.bbapap.2010.04.001 ↗
12. Aβ plaque-selective NIR fluorescence probe to differentiate Alzheimer's disease from tauopathies10.1016/j.bios.2017.06.030 ↗
13. A high affinity red fluorescence and colorimetric probe for amyloid β aggregates10.1038/srep23668 ↗
14. Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease10.1073/pnas.1505420112 ↗
15. Synthesis and evaluation of styrylpyran fluorophores for noninvasive detection of cerebral β-amyloid deposits10.1016/j.bmc.2016.01.004 ↗
16. In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe10.1038/nbt1085 ↗
17. Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits10.1021/ja4052922 ↗
18. Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-β deposits10.1021/ja9047043 ↗
19. In vivo detection of cerebral amyloid fibrils with smart dicynomethylene-4H-pyran-based fluorescence probe10.1021/acs.analchem.5b00017 ↗
20. Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease10.1021/ja405239v ↗
21. Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology10.1007/s00259-007-0708-7 ↗
22. In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-26510.3233/JAD-2010-100270 ↗
23. Evaluation of molecules based on the electron donor-acceptor architecture as near-infrared β-amyloidal-targeting probes10.1039/C4CC04907A ↗
24. Two-photon absorbing dyes with minimal autofluorescence in tissue imaging: application to in vivo imaging of amyloid-β plaques with a negligible background signal10.1021/jacs.5b03548 ↗
25. Designing BODIPY-based probes for fluorescence imaging of β-amyloid plaques10.1039/C4RA07754G ↗
26. Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimers disease10.1016/j.apsb.2014.12.006 ↗
27. In vivo near-infrared fluorescence imaging of amyloid-β plaques with a dicyanoisophorone-based probe10.1016/j.aca.2017.01.017 ↗
28. Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease10.1039/C8RA03620A ↗
29. Imaging of β-amyloid plaques by near infrared fluorescent tracers: a new frontier for chemical neuroscience10.1039/C4CS00337C ↗
30. Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes10.4155/fmc-2016-0185 ↗
31. In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers10.1002/anie.200500845 ↗
32. Tailoring hydrophobic interactions between probes and amyloid-β peptides for fluorescent monitoring of amyloid-β aggregation10.1021/acsomega.8b00286 ↗
33. A solo fluorogenic probe for the real-time sensing of SO32- and SO42-/HSO4- in aqueous medium and live cells by distinct turn-on emission signals10.1039/C6CC03910C ↗
34. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution10.1002/pro.5560020312 ↗
35. Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease10.1038/ncomms13115 ↗
36. Structural and mechanistic insights into development of chemical tools to control individual and inter-related pathological features in Alzheimer's disease10.1002/chem.201605401 ↗
37. Enhanced chemiluminescence (ECL) for routine immunoblotting: an inexpensive alternative to commercially available kits10.4161/spmg.1.2.16606 ↗
38. A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: in vitro and in vivo efficacy and molecular mechanisms10.1021/jacs.5b10043 ↗
39. Importance of the dimethylamino functionality on a multifunctional framework for regulating metals, amyloid-β, and oxidative stress in Alzheimer's disease10.1021/acs.inorgchem.6b00525 ↗
40. Mechanistic insights into tunable metal-mediated hydrolysis of amyloid-β peptides10.1021/jacs.6b09681 ↗
41. Endoplasmic reticulum-localized iridium(III) complexes as efficient photodynamic therapy agents via protein modifications10.1021/jacs.6b05302 ↗
42. Rational design of amyloid binding agents based on the molecular rotor motif10.1002/cmdc.200900440 ↗
43. Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer's disease10.1002/cbic.201402718 ↗
44. Misfolded proteins in Alzheimer's disease and type II diabetes10.1039/C1CS15112F ↗
45. Chemical fluorescent probe for detection of Aβ oligomers10.1021/jacs.5b06190 ↗
46. A spiropyran-based fluorescent probe for the specific detection of β-amyloid peptide oligomers in Alzheimer's disease10.1039/C6CC02741E ↗
47. Detection of Aβ plaques in mouse brain by using a disaggregation-induced fluorescence-enhancing probe10.1039/c4cc02011a ↗
48. D-A-D fluorogenic probe for the rapid imaging of amyloid β plaques in vivo10.1016/j.dyepig.2016.08.054 ↗
49. Bivalent ligand containing curcumin and cholesterol as fluorescence probe for Aβ plaques in Alzheimer's disease10.1021/cn200122j ↗
50. Thioflavin T as a molecular rotor: fluorescent properties of thioflavin T in solvents with different viscosity10.1021/jp805822c ↗
51. Fluorescence anisotropy of molecular rotors10.1002/cphc.201000782 ↗
52. Disaggregation-induced fluorescence enhancement of NIAD-4 for the optical imaging of amyloid-β fibrils10.1039/C5CP02728D ↗
53. Auramine-O as a fluorescence marker for the detection of amyloid fibrils10.1021/jp310232b ↗
54. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers10.1186/1750-1326-2-18 ↗
55. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis10.1126/science.1079469 ↗
56. Ubiquitin: structures, functions, mechanisms10.1016/j.bbamcr.2004.09.019 ↗